← Eichor
Study identifier: NCT06238232 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism

Condition: Primary Aldosteronism  ·  Sponsor: Qifu Li

PhaseNA
Planned participants320
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

To compare the 68Ga-Pentixafor PET/CT and adrenal vein sampling on the long-term outcomes of primary aldosteronism (PA) patients with adrenal nodule (≥1cm)

This description comes directly from the study's public registry record.

Talk to the study team

Qifu Li, PhD  ·  +86 023-89011552  ·  liqifu@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affilated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06238232